Fig. 1

Overview of the healthcare journey of patients with RET-altered thyroid cancer

Details: Services provided during screening, diagnosis, treatment, monitoring, management and palliative care. Differences by country are demonstrated in italics. The top 3 specialists involved at each stage of the patient journey are reported on the right

Legend: MEN2 = Multiple endocrine neoplasia type 2, PC = parathyroid carcinoma, PHEO = phleochromocytoma, FNA = fine needle aspiration, TSH = thyroid stimulating hormone, Tg = thyroglobulin, NGS = next generation sequencing, FISH = fluorescence in situ hybridization, DTC = differentiated thyroid carcinoma such as papillary or follicular thyroid carcinoma, TKI = tyrosine kinase inhibitor, ENDO = endocrinologist, MED. ONC = medical oncologist, T. SUR = thyroid surgeon, GP = general practitioner or primary care physician, ENT = otorhinolaryngologist or ear-nose-throat specialist, PATH = pathologist, PAL = palliative care physician, GER = Germany, UK = United Kingdom, JPN = Japan, US = United States.